Added to YB: 2022-05-01
Pitch date: 2022-05-01
ATHA [bullish]
Athira Pharma, Inc.
-96.24%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Athira Pharma, Inc., clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation.
Market Cap
$15.8M
Pitch Price
$102.80
Price Target
N/A
Dividend
N/A
EV/EBITDA
-0.02
P/E
-0.42
EV/Sales
N/A
Sector
Pharmaceuticals
Category
N/A
Show full summary:
ATHIRA PHARMA INC ATHA
A summary for this pitch has not been created yet.
Read full article (0 min)